Cheaper antibiotic challenge to stop deadly gut infection comebacks
NCT ID NCT07328971
Summary
This study aims to see if a specific, tapering schedule of the antibiotic vancomycin works as well as another antibiotic, fidaxomicin, at preventing C. difficile infections from coming back. It will enroll 500 adults experiencing their first or second C. diff infection. The goal is to find a more affordable and widely available treatment option that can keep the infection from recurring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIA DIFFICILE COLITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
McGill University Health Centre
Montreal, Quebec, H4A0B1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.